Medicare Coverage Processes: An Analysis of Procedural and Resource Concerns
This report focuses on coverage for devices and issues related to procedural delays, the lack of transparency in Medicare’s National Coverage Determination (NCD) process, the use of Coverage with Evidence Development, harmonizing with the Food and Drug Administration (FDA), and ensuring patient safety. CMS has conducted its NCD review process for medical devices for many years but in recent years the process has slowed and become less predictable. The operational flaws that exist within the NCD process ultimately could prevent Medicare beneficiaries from accessing innovative technologies, especially at a time when CMS considers assuming new responsibilities for evaluating new technologies.
Related Reading
News / Coverage & Payment / Government & Legislative Affairs
AdvaMed Welcomes Bipartisan Senate Bill to Expedite Medicare Coverage of Breakthrough Medical Technologies, Diagnostic Tests
November 20, 2024
AdvaMed, the Medtech Association, today welcomed introduction in the U.S. Senate of bipartisan legislation to expedite Medicare coverage of FDA-“breakthrough”-designated medical technologies and diagnostic tests. The legislation, the Ensuring Patient Access to Critical Breakthrough Products Act, introduced by Sen. Todd Young (R-IN) and Sen. Alex Padilla (D-CA), is similar to H.R. 1691, which the U.S. House of Representatives Ways and Means Committee passed on a bipartisan basis in June.
News / Coverage & Payment
AdvaMed: Final CMS Payment Rules Contain Significant Victories for Patients
November 7, 2024
AdvaMed, the Medtech Association, today said two new final payment rules from the Centers for Medicare and Medicaid Services (CMS) for 2025 contain several important provisions that will improve access to care and improve outcomes for millions of Medicare beneficiaries. The measures include longstanding priorities for patient groups, providers, and medtech innovators.
News / Coverage & Payment / Medical Imaging
AdvaMed Calls on Medicare to Cover Supplemental Imaging as Part of Breast Cancer Screening
November 4, 2024
AdvaMed, the Medtech Association, called on Medicare in a letter sent Friday to cover supplemental imaging for women with heterogeneously and extremely dense breast tissue, noting the life-saving value of the additional screening and the pressing health equity needs Medicare coverage of these critical services would address.
News / Coverage & Payment
AdvaMed: Final CMS Hospital Outpatient Payment Rule Contains Significant Improvement for Patient Access to Care
September 17, 2024
News / Coverage & Payment
AdvaMed Statement on Final TCET Notice
August 8, 2024
AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on the final Transitional Coverage for Emerging Technologies (TCET) notice from the Centers for Medicare and Medicaid Services (CMS).
News / Coverage & Payment / Government & Legislative Affairs
AdvaMed Hosts Showcase on Capitol Hill, Urges Action on Reimbursement Pathway for AI-Enabled Medical Technology
July 26, 2024
This week, AdvaMed, the Medtech Association, hosted an Artificial Intelligence (AI) Demonstration Day event on Capitol Hill showcasing AI-enabled medical devices and technologies from leading health care companies. The event was honorarily co-hosted by Senators Martin Heinrich (D-NM) and Mike Rounds (R-SD), co-chairs of the Senate AI Caucus.
News / Coverage & Payment
AdvaMed Praises CMS Draft Rule Improving Patient Access to Alzheimer’s, Cancer Diagnostics
July 11, 2024
Today, the Centers for Medicare and Medicaid Services (CMS) issued the Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System proposed rule for CY25, which includes significant wins for patients, including separate payments for diagnostic radiopharmaceuticals, which improves access and ensures better treatment and care. Also of note, CMS’s proposed rule includes coverage for CT Colonography, or virtual colonoscopy, an important tool in detecting colorectal cancer.
News / Coverage & Payment / Government & Legislative Affairs
House Committee Advances Bipartisan Bill to Expedite CMS Coverage of Breakthrough Medtech
June 27, 2024
The House Ways and Means Committee voted to pass the bipartisan H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act, during a markup meeting.